Opiant Pharmaceuticals OverviewOpiant Pharmaceuticals Operating Income
Operating Income for OPNT.
Quarterly Operating Income
$-9629784.00
↓ 343.15% YoY
As of Sep 30, 2022
Annual Operating Income (TTM)
$-31503877.00
↓ 1198.5% YoY
Trailing 12 months ending Sep 30, 2022